Screener
Regeneron Pharmaceuticals REGN Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's free cash flow margin?
- Regeneron Pharmaceuticals (REGN) reported free cash flow margin of 24.2% in Q2 2026.
- How has Regeneron Pharmaceuticals's free cash flow margin changed year-over-year?
- Regeneron Pharmaceuticals's free cash flow margin decreased by 10.7% year-over-year, from 27.1% to 24.2%.
- What is the long-term trend for Regeneron Pharmaceuticals's free cash flow margin?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's free cash flow margin has grown at a -8.5% compound annual growth rate (CAGR), from 40.6% to 28.4%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Regeneron Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude